Cargando…
Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
Many clinical studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) have renoprotective properties by ameliorating albuminuria and increasing glomerular filtration rate in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) by lowering ectopic li...
Autores principales: | Yeung, Martin Ho Yin, Leung, Ka Long, Choi, Lai Yuen, Yoo, Jung Sun, Yung, Susan, So, Pui-Kin, Wong, Chi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921774/ https://www.ncbi.nlm.nih.gov/pubmed/35299724 http://dx.doi.org/10.3389/fphar.2021.777395 |
Ejemplares similares
-
Preventive Effects of Dulaglutide on Disuse Muscle Atrophy Through Inhibition of Inflammation and Apoptosis by Induction of Hsp72 Expression
por: Nguyen, Tram Thi Ngoc, et al.
Publicado: (2020) -
Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
por: Kalra, Sanjay, et al.
Publicado: (2012) -
Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
por: Hu, Shanshan, et al.
Publicado: (2022) -
GLP-1 Receptor: A New Target for Sepsis
por: Yang, Fuxun, et al.
Publicado: (2021) -
Lipidome profiles of postnatal day 2 vaginal swabs reflect fat composition of gilt’s postnatal diet
por: Harlow, KaLynn, et al.
Publicado: (2019)